A. D. Van den Abbeele

发表

Centralized Clinical Trial Imaging Data Management: Practical Guidance from a Comprehensive Cancer Center’s Experience

Brandon Lee, A. Abbott, S. Davidson, 2018, Journal of Digital Imaging.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

A. D. Van den Abbeele, J. Fletcher, G. Demetri, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Major response to imatinib mesylate in KIT-mutated melanoma.

A. D. Van den Abbeele, G. Demetri, F. Hodi, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

A. D. Van den Abbeele, S. Silverman, D. Tuveson, 2002, The New England journal of medicine.

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

A. D. Van den Abbeele, A. Giobbie-Hurder, K. Flaherty, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events.

A. D. Van den Abbeele, S. Tirumani, H. Jacene, 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Joel Karp, A. D. Van den Abbeele, Daniel Sullivan, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Theranostics: The Role of Quantitative Nuclear Medicine Imaging.

A. D. Van den Abbeele, R. Wahl, M. Graham, 2021, Seminars in radiation oncology.

Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma

A. D. Van den Abbeele, J. Friedberg, G. Demetri, 1999, Cancer.

Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.

A. D. Van den Abbeele, Sukru Mehmet Erturk, H. Otero, 2009, AJR. American journal of roentgenology.

Impact of Acquisition Geometry, Image Processing, and Patient Size on Lesion Detection in Whole-Body 18F-FDG PET

Georges El Fakhri, A. D. Van den Abbeele, Ramsey D Badawi, 2007, Journal of Nuclear Medicine.

5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.

A. D. Van den Abbeele, P. Black, S. Adelstein, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).

A. D. Van den Abbeele, Ramsey D Badawi, Annick D Van den Abbeele, 2002, European journal of cancer.

Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

A. D. Van den Abbeele, A. Giobbie-Hurder, M. Mihm, 2014, Cancer Immunology Research.

Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro.

Alun G. Jones, A. D. Van den Abbeele, B. Holman, 1990, Cancer research.

Return of lymphatic function after flap transfer for acute lymphedema.

A. D. Van den Abbeele, M. Swartz, A. Losken, 1999, Annals of surgery.

An Investigation of Lymphatic Function Following Free‐Tissue Transfer

A. D. Van den Abbeele, J. Upton, S. Slavin, 1997, Plastic and reconstructive surgery.

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

Kristen L. Jones, A. D. Van den Abbeele, Kristen L Jones, 2015, Cancer Immunology Research.

Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma

A. D. Van den Abbeele, C. Shapiro, W. Kaplan, 2001, Cancer.

Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice

A. D. Van den Abbeele, Su-Chun Cheng, H. Jacene, 2018, Nuclear medicine communications.

Importance of 68Ga-FAPI PET/CT for Detection of Cancer.

A. D. Van den Abbeele, F. Jacobson, 2022, Radiology.

Imaging of lung cancer in the era of molecular medicine.

Hiroto Hatabu, A. D. Van den Abbeele, Annick D Van den Abbeele, 2011, Academic radiology.

Combination signal transduction inhibition: a phase I/II trial of the oral mTOR-inhibitor everolimus (E, RAD001) and imatinib mesylate (IM) in patients (pts) with gastrointestinal stromal tumor (GIST) refractory to IM.

A. D. Van den Abbeele, G. Demetri, J. Kovarik, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.

Hiroto Hatabu, A. D. Van den Abbeele, Annick D Van den Abbeele, 2010, AJR. American journal of roentgenology.

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

A. D. Van den Abbeele, G. Demetri, J. Yap, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imaging Androgen Receptors in Breast Cancer with 18F-Fluoro-5α-Dihydrotestosterone PET: A Pilot Study

A. D. Van den Abbeele, Su-Chun Cheng, B. Overmoyer, 2021, The Journal of Nuclear Medicine.

Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.

A. D. Van den Abbeele, E. Winer, Minetta C. Liu, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.

A. D. Van den Abbeele, A. Aghayev, C. Sakellis, 2015, Clinical nuclear medicine.

End-Therapy Positron Emission Tomography for Treatment Response Assessment in Follicular Lymphoma: A Systematic Review and Meta-analysis

A. D. Van den Abbeele, Jennifer R. Brown, H. Jacene, 2013, Clinical Cancer Research.

Clinical Investigation : Lymphoma Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma : Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET

A. D. Van den Abbeele, A. LaCasce, P. Catalano, 2012 .

Targeting the follicular lymphoma microenvironment through blockade of TNFα with etanercept

A. D. Van den Abbeele, J. Friedberg, D. Neuberg, 2008, Leukemia & lymphoma.

Phase II trial of lapatinib for brain metastases in patients with HER2+ breast cancer.

A. D. Van den Abbeele, E. Winer, L. Carey, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Atypical metastases from prostate cancer: 10-year experience at a single institution.

A. D. Van den Abbeele, A. Shinagare, W. Oh, 2012, AJR. American journal of roentgenology.

Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.

A. D. Van den Abbeele, A. LaCasce, A. Ng, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.

A. D. Van den Abbeele, P. Jänne, J. Yap, 2011, Academic radiology.

Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.

A. D. Van den Abbeele, J. Fletcher, G. Demetri, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.

A. D. Van den Abbeele, E. Lepisto, A. Kassis, 1989, American journal of obstetrics and gynecology.

Antigen-binding site protection during radiolabeling leads to a higher immunoreactive fraction.

A. D. Van den Abbeele, S. Adelstein, A. Kassis, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Will ultra-extended field-of-view scanners be an expensive folly or the next clinical standard for PET/CT?

A. D. Van den Abbeele, R. Hicks, 2022, Cancer Imaging.

Adult extragonadal germ cell tumors.

A. D. Van den Abbeele, A. Shinagare, J. Jagannathan, 2010, AJR. American journal of roentgenology.

Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center

A. D. Van den Abbeele, A. Shinagare, H. Hatabu, 2011, Cancer.

FDG-PET is Superior to Gallium Scintigraphy in Staging and More Sensitive in the Follow-up of Patients with de novo Hodgkin Lymphoma: A Blinded Comparison

A. D. Van den Abbeele, J. Friedberg, A. Fischman, 2004, Leukemia & lymphoma.

The Lessons of GIST — PET and PET / CT : A New Paradigm for Imaging

A. D. Van den Abbeele, A. D. Abbeele, 2008 .

Use of computerized tomography (CT) as an early prognostic indicator of response to imatinib mesylate (IM) in patients with gastrointestinal stromal tumors (GIST).

A. D. Van den Abbeele, J. Manola, G. Demetri, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of cessation of imatinib mesylate (IM) therapy in patients (pts) with IM-refractory gastrointestinal stromal tumors (GIST) as visualized by FDG-PET scanning.

A. D. Van den Abbeele, J. Manola, G. Demetri, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas

A. D. Van den Abbeele, J. Manola, J. Desai, 2004, Clinical Cancer Research.

When is hilar uptake of 67Ga-citrate indicative of residual disease after CHOP chemotherapy?

A. D. Van den Abbeele, J. L. Chen, D. Neuberg, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evolution of Transarterial Chemoembolization for the Treatment of Liver Cancer.

A. D. Van den Abbeele, K. Kim, 2019, Radiology.

CT and PET/CT findings of T-cell lymphoma.

A. D. Van den Abbeele, H. Otero, L. Prevedello, 2009, AJR. American journal of roentgenology.

Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.

A. D. Van den Abbeele, G. Mariani, P. Viacava, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Inhomogeneous deposition of radiopharmaceuticals at the cellular level: experimental evidence and dosimetric implications.

D. W. Vinter, A. D. Van den Abbeele, S. Adelstein, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.

A. D. Van den Abbeele, G. Demetri, B. Eisenberg, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

Clonal evolution of resistance to imatinib (IM) in patients (pts) with gastrointestinal stromal tumor (GIST): molecular and radiologic evaluation of new lesions.

A. D. Van den Abbeele, S. Silverman, K. Tuncali, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST).

A. D. Van den Abbeele, J. Fletcher, G. Demetri, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5-[123I]iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model.

A. D. Van den Abbeele, S. Adelstein, A. Kassis, 1991, International journal of radiation oncology, biology, physics.

Imaging of extraosseous myeloma: CT, PET/CT, and MRI features.

A. D. Van den Abbeele, A. Shinagare, J. Jagannathan, 2010, AJR. American journal of roentgenology.

Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division

A. D. Van den Abbeele, H. Jacene, M. Kulke, 2018, The Journal of Nuclear Medicine Technology.

Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans.

A. D. Van den Abbeele, P. Black, S. Adelstein, 1990, Cancer research.

Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.

A. D. Van den Abbeele, Annick D Van den Abbeele, J. Jagannathan, 2010, AJR. American journal of roentgenology.

Noninvasive Imaging of Cancer Immunotherapy

A. D. Van den Abbeele, M. Kircher, Omar B. Abousaway, 2021, Nanotheranostics.

Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

A. D. Van den Abbeele, E. Winer, L. Cantley, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vesicoureteral reflux in asymptomatic siblings of patients with known reflux: radionuclide cystography.

A. D. Van den Abbeele, Royal T. Davis, S. Treves, 1987, Pediatrics.

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

A. D. Van den Abbeele, A. LaCasce, M. Millenson, 2012, Blood.

Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer

A. D. Van den Abbeele, T. Dang, R. Herbst, 2007, Clinical Cancer Research.

PET imaging of Gastrointestinal Stromal Tumors (GIST)

A. D. Van den Abbeele, S. George, C. Sakellis, 2022, Reference Module in Biomedical Sciences.

Considerations for the Use of Imaging Tools for Phase II Treatment Trials in Oncology

A. D. Van den Abbeele, L. Shankar, T J Fitzgerald, 2009, Clinical Cancer Research.

Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib

A. D. Van den Abbeele, G. Demetri, P. Pedrazzoli, 2009, Pediatric blood & cancer.

Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine.

A. D. Van den Abbeele, S P Bartold, H D Royal, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.

Qian Wang, A. D. Van den Abbeele, Edwin Choy, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of regorafenib activity with FDG-PET/CT in a multicenter phase II study in patients (pts) with advanced gastrointestinal stromal tumor (GIST) following failure of standard therapy (Rx).

A. D. Van den Abbeele, J. Manola, G. Demetri, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.

A. D. Van den Abbeele, J. Manola, M. Loda, 2015, Clinical genitourinary cancer.

Platelet activation and aggregation after endothelial injury. Assessment with indium-111-labeled platelets and angiography.

A. D. Van den Abbeele, B. Holman, A. Kassis, 1990, Investigative radiology.

NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

A. D. Van den Abbeele, J. Blay, D. Ettinger, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure

A. D. Van den Abbeele, C. Antonescu, J. Fletcher, 2009, Clinical Cancer Research.

Infrequent Tumors of the Gastrointestinal Tract Including Gastrointestinal Stromal Tumor (GIST).

A. D. Van den Abbeele, Mehmet Ertuk, 2008, PET clinics.

FDG-PET to Measure Response to Targeted Therapy: The Example of Gastrointestinal Stromal Tumor and Imatinib Mesylate (Gleevec).

A. D. Van den Abbeele, Mehmet Ertuk, 2008, PET clinics.

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.

A. D. Van den Abbeele, J. Fraumeni, J. Garber, 2008, JAMA.

Cancer Imaging Training in the 21st Century: An Overview of Where We Are, and Where We Need To Be.

A. D. Van den Abbeele, S. Seltzer, B. Weissman, 2015, Journal of the American College of Radiology : JACR.

The Treatment and Outcome of Cancer Patients with Thromboses on Central Venous Catheters

A. D. Van den Abbeele, J. Ibrahim, D. Hirsch, 2000, Journal of Thrombosis and Thrombolysis.

Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study

A. D. Van den Abbeele, J. Crowley, D. Flieder, 2019, Clinical Cancer Research.

Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma.

Ivan Pedrosa, A. D. Van den Abbeele, Annick D Van den Abbeele, 2011, European Urology.

Case report. PET/CT appearance of desmoid tumour of the chest wall.

A. D. Van den Abbeele, F. Fennessy, Q. Yang, 2010, The British journal of radiology.

10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study.

A. D. Van den Abbeele, T. Choueiri, M. Nishino, 2014, The oncologist.

Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors

A. D. Van den Abbeele, J. Manola, J. Desai, 2007, Clinical Cancer Research.

ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression

A. D. Van den Abbeele, C. Gatsonis, J. Sicks, 2012, The Journal of Nuclear Medicine.

CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor.

A. D. Van den Abbeele, Ramsey D Badawi, Annick D Van den Abbeele, 2007, AJR. American journal of roentgenology.

Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate.

A. D. Van den Abbeele, J. Desai, G. Demetri, 2005, Radiology.

Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma

A. D. Van den Abbeele, A. Giobbie-Hurder, G. Linette, 2015, Cancer.

Absence of preferential uptake of [125I]iododihydrorhodamine 123 by four human tumor xenografts.

A. D. Van den Abbeele, S. Adelstein, A. Kassis, 1989, Cancer research.

Surveillance imaging of Hodgkin lymphoma patients in first remission

A. D. Van den Abbeele, A. LaCasce, D. Neuberg, 2010, Cancer.

Urothelial Cancers of the Upper Urinary Tract: Metastatic Pattern and Its Correlation With Tumor Histopathology and Location

A. D. Van den Abbeele, F. Fennessy, A. Shinagare, 2011, Journal of computer assisted tomography.

Imaging in renal cell carcinoma.

A. D. Van den Abbeele, I. Pedrosa, K. Krajewski, 2011, Hematology/oncology clinics of North America.

Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence

A. D. Van den Abbeele, J. Jagannathan, N. Ramaiya, 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

Immune Modulation Therapy and Imaging: Workshop Report

A. D. Van den Abbeele, E. Jaffee, M. Graham, 2017, The Journal of Nuclear Medicine.

Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma

A. D. Van den Abbeele, A. Giobbie-Hurder, F. Hodi, 2014, Cancer Imaging.

Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.

A. D. Van den Abbeele, F. Fennessy, A. Shinagare, 2011, AJR. American journal of roentgenology.

A potential murine model for flap-related investigations.

A. D. Van den Abbeele, M. Swartz, A. Losken, 2001, Plastic and reconstructive surgery.

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

A. D. Van den Abbeele, E. Winer, A. Richardson, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.

A. D. Van den Abbeele, R. Birdwell, J. Bellon, 2013, Radiographics : a review publication of the Radiological Society of North America, Inc.

F-18 FDG PET/CT in the diagnosis and management of a pericardiac paraganglioma.

A. D. Van den Abbeele, M. Kulke, N. Sheehy, 2008, Clinical nuclear medicine.

Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.

A. D. Van den Abbeele, A. Ng, B. Silver, 2005, International journal of radiation oncology, biology, physics.

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors

A. D. Van den Abbeele, R. Wahl, A. Dimitrakopoulou-Strauss, 2022, Cancer imaging : the official publication of the International Cancer Imaging Society.

Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer

A. D. Van den Abbeele, A. Shinagare, N. Ramaiya, 2017, Abdominal Radiology.

Venous Thrombosis in an Outpatient Oncologic Center: Distribution, Type, and Comorbidities

A. D. Van den Abbeele, F. Rybicki, D. D. Di Salvo, 2009, Ultrasound quarterly.

LesionTracker: Extensible Open-Source Zero-Footprint Web Viewer for Cancer Imaging Research and Clinical Trials.

Erik Ziegler, Rob Lewis, A. D. Van den Abbeele, 2017, Cancer research.

Advanced High-Grade Serous Ovarian Cancer: Frequency and Timing of Thoracic Metastases and the Implications for Chest Imaging Follow-up.

A. D. Van den Abbeele, A. Shinagare, S. Tirumani, 2015, Radiology.

Surveillance Imaging in Patients With Endometrial Cancer in First Remission.

A. D. Van den Abbeele, Su-Chun Cheng, H. Jacene, 2017, Current problems in diagnostic radiology.

A phase I trial of ipilimumab plus bevacizumab in patients with unresectable stage III or stage IV melanoma.

A. D. Van den Abbeele, A. Giobbie-Hurder, M. Atkins, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of PET response after long-term sunitinib therapy in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumors (GIST).

A. D. Van den Abbeele, M. Bertagnolli, G. Demetri, 2006, Journal of Clinical Oncology.

Safety and efficacy of percutaneous radio-frequency ablation (RFA) in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) with clonal evolution of lesions refractory to imatinib mesylate (IM).

A. D. Van den Abbeele, S. Silverman, K. Tuncali, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TBCRC 003: Phase II trial of trastuzumab (T) and lapatinib (L) in patients (pts) with HER2+ metastatic breast cancer (MBC).

A. D. Van den Abbeele, E. Winer, R. Gelman, 2010, Journal of Clinical Oncology.

Positron emission tomography with 18F‐fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer

A. D. Van den Abbeele, R. Tishler, R. Haddad, 2004, Head & neck.

Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.

A. D. Van den Abbeele, A. Shinagare, S. Tirumani, 2017, Radiology.

Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis.

A. D. Van den Abbeele, A. Shinagare, N. Ramaiya, 2018, Clinical radiology.

Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.

A. D. Van den Abbeele, P. Black, S. Adelstein, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical, Radiographic, and Biochemical Characterization of Multiple Myeloma Patients with Osteonecrosis of the Jaw

A. D. Van den Abbeele, N. Munshi, P. Richardson, 2008, Clinical Cancer Research.

[18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments1

A. D. Van den Abbeele, Su-Chun Cheng, N. Kohl, 2015, Translational oncology.

Assessment of response using FDG-PET and CT in a phase I study of AMN107 alone or in combination with imatinib (IM) in patients with imatinib-resistant (IM-R) gastrointestinal stromal tumors (GIST).

A. D. Van den Abbeele, G. Demetri, W. Hayes, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HPLC analysis of the dissociation and recombination of rabbit immunoglobulin G.

A. D. Van den Abbeele, S. Adelstein, A. Kassis, 1987, Journal of immunological methods.

Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model

Andrea Protti, A. D. Van den Abbeele, Annick D Van den Abbeele, 2018, PloS one.

Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center.

A. D. Van den Abbeele, F. Fennessy, S. Tirumani, 2016, Journal of the American College of Radiology.

Hereditary cancer syndromes: a radiologist's perspective.

A. D. Van den Abbeele, A. Shinagare, J. Jagannathan, 2011, AJR. American journal of roentgenology.

A multicenter phase II study of regorafenib in patients (pts) with advanced gastrointestinal stromal tumor (GIST), after therapy with imatinib (IM) and sunitinib (SU).

A. D. Van den Abbeele, J. Manola, J. Fletcher, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.

A. D. Van den Abbeele, J. Richie, S. Adelstein, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Ovarian Cancer: An Evidence-Based, Easy-to-Use Prediction Rule to Optimize the Use of Follow-up Chest CT.

A. D. Van den Abbeele, A. Shinagare, K. Kim, 2017, Journal of the American College of Radiology : JACR.

Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome

A. D. Van den Abbeele, N. Munshi, A. Shinagare, 2016, Clinical nuclear medicine.

Report on the PET/CT Image–Based Radiation Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer

A. D. Van den Abbeele, Su-Chun Cheng, B. Overmoyer, 2023, The Journal of Nuclear Medicine Technology.

Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era.

A. D. Van den Abbeele, F. Fennessy, A. Shinagare, 2017, Journal of the American College of Radiology : JACR.